Speaker(s): 

Gionna Knauss, PharmD, PGY2 Oncology Resident, Geisinger - has nothing to disclose.

Maria Saimbert, PharmD, PGY2 Oncology Resident, Geisinger - has nothing to disclose.

Moderator(s): 

Tristan Maiers, PharmD, BCOP, Oncology Pharmacist, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Review background data on CMV prophylaxis recommendations and asparaginase reactions 

• Describe methods to single-center study conducted at Geisinger Cancer Institute

• Understand internal data seen with patients at Geisinger and recommendations for practice moving forward

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Rajiv Panikkar, MD, Michele Long, BSN, Jaime Weeder, NP and Christopher Kashi, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.